Zhao Xinyu, Rangaprakash D, Yuan Bowen, Denney Thomas S, Katz Jeffrey S, Dretsch Michael N, Deshpande Gopikrishna
Department of Electrical and Computer Engineering, AU MRI Research Center, Auburn University, Auburn, AL, United States.
Quora, Inc., Mountain View, CA, United States.
Front Appl Math Stat. 2018 Sep;4. doi: 10.3389/fams.2018.00025. Epub 2018 Sep 25.
Many brain-based disorders are traditionally diagnosed based on clinical interviews and behavioral assessments, which are recognized to be largely imperfect. Therefore, it is necessary to establish neuroimaging-based biomarkers to improve diagnostic precision. Resting-state functional magnetic resonance imaging (rs-fMRI) is a promising technique for the characterization and classification of varying disorders. However, most of these classification methods are supervised, i.e., they require clinical labels to guide classification. In this study, we adopted various unsupervised clustering methods using static and dynamic rs-fMRI connectivity measures to investigate whether the clinical diagnostic grouping of different disorders is grounded in underlying neurobiological and phenotypic clusters. In order to do so, we derived a general analysis pipeline for identifying different brain-based disorders using genetic algorithm-based feature selection, and unsupervised clustering methods on four different datasets; three of them-ADNI, ADHD-200, and ABIDE-which are publicly available, and a fourth one-PTSD and PCS-which was acquired in-house. Using these datasets, the effectiveness of the proposed pipeline was verified on different disorders: Attention Deficit Hyperactivity Disorder (ADHD), Alzheimer's Disease (AD), Autism Spectrum Disorder (ASD), Post-Traumatic Stress Disorder (PTSD), and Post-Concussion Syndrome (PCS). For ADHD and AD, highest similarity was achieved between connectivity and phenotypic clusters, whereas for ASD and PTSD/PCS, highest similarity was achieved between connectivity and clinical diagnostic clusters. For multi-site data (ABIDE and ADHD-200), we report site-specific results. We also reported the effect of elimination of outlier subjects for all four datasets. Overall, our results suggest that neurobiological and phenotypic biomarkers could potentially be used as an aid by the clinician, in additional to currently available clinical diagnostic standards, to improve diagnostic precision. Data and source code used in this work is publicly available at https://github.com/xinyuzhao/identification-of-brain-based-disorders.git.
许多基于大脑的疾病传统上是通过临床访谈和行为评估来诊断的,而这些方法被认为在很大程度上并不完善。因此,有必要建立基于神经影像学的生物标志物以提高诊断精度。静息态功能磁共振成像(rs-fMRI)是一种用于表征和分类各种疾病的很有前景的技术。然而,这些分类方法大多是有监督的,即它们需要临床标签来指导分类。在本研究中,我们采用了各种无监督聚类方法,利用静态和动态rs-fMRI连接性测量来研究不同疾病的临床诊断分组是否基于潜在的神经生物学和表型聚类。为了做到这一点,我们推导了一个通用的分析流程,用于使用基于遗传算法的特征选择和四个不同数据集上的无监督聚类方法来识别不同的基于大脑的疾病;其中三个——ADNI、ADHD-200和ABIDE——是公开可用的,还有第四个——创伤后应激障碍(PTSD)和脑震荡后综合征(PCS)——是内部获取的。使用这些数据集,所提出的流程在不同疾病上的有效性得到了验证:注意力缺陷多动障碍(ADHD)、阿尔茨海默病(AD)、自闭症谱系障碍(ASD)、创伤后应激障碍(PTSD)和脑震荡后综合征(PCS)。对于ADHD和AD,连接性聚类与表型聚类之间的相似性最高,而对于ASD和PTSD/PCS,连接性聚类与临床诊断聚类之间的相似性最高。对于多站点数据(ABIDE和ADHD-200),我们报告了特定站点的结果。我们还报告了在所有四个数据集中剔除异常值受试者的影响。总体而言,我们的结果表明,除了目前可用的临床诊断标准外,神经生物学和表型生物标志物有可能被临床医生用作辅助手段,以提高诊断精度。本研究中使用的数据和源代码可在https://github.com/xinyuzhao/identification-of-brain-based-disorders.git上公开获取。